arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2406.18690cs.HCcs.AIcs.LG
收藏

Petal-X:以人为中心的视觉解释以改善心血管风险沟通

Petal-X: Human-Centered Visual Explanations to Improve Cardiovascular Risk Communication

KU Leuven(鲁汶大学);University of Amsterdam(阿姆斯特丹大学);University of Maribor(马里博尔大学)

Diego Rojo, Houda Lamqaddam, Lucija Gosak, Katrien Verbert

AI总结:

本文提出Petal-X工具,通过Petal Product Plots可视化和SCORE2全局代理模型支持医患共同决策,在关键风险沟通任务上优于传统图形评分图,且不损失透明度与信任度。

摘要:

心血管疾病是全球首要死因,但大多数病例可通过行为干预来预防。因此,有效沟通CVD风险及通过改变风险因素带来的预期风险降低,对于在个体层面降低CVD风险至关重要。然而,尽管人们一直对利用改进的预测模型(如SCORE2)来完善风险估计感兴趣,但在临床实践中呈现这些风险估计的指南在过去几年中基本保持不变,图形评分图仍是主要的系统之一。本工作描述了Petal-X的设计与实现,这是一个通过解释不同因素的CVD风险贡献并促进假设分析来支持医患共同决策的新颖工具。Petal-X依赖于一种新颖的可视化——Petal Product Plots,以及一个为SCORE2量身定制的全局代理模型,其保真度与临床实践中使用的GSC相当。我们在一项对照实验中,以88名医疗保健专业学生为对象(除一人外均有慢性病患者接触经验),评估了Petal-X与GSC的对比效果。结果显示,在比较每个可改变风险因素对患者10年CVD风险的贡献等关键任务上,Petal-X优于GSC,且在感知透明度、信任度或使用意愿上没有显著下降。我们的研究为临床实践中的风险可视化与解释提供了创新方法,由于其模型无关的特性,该方法可继续支持下一代人工智能风险评估模型。

英文摘要:

Cardiovascular diseases (CVDs), the leading cause of death worldwide, can be prevented in most cases through behavioral interventions. Therefore, effective communication of CVD risk and projected risk reduction by risk factor modification plays a crucial role in reducing CVD risk at the individual level. However, despite interest in refining risk estimation with improved prediction models such as SCORE2, the guidelines for presenting these risk estimations in clinical practice remained essentially unchanged in the last few years, with graphical score charts (GSCs) continuing to be one of the prevalent systems. This work describes the design and implementation of Petal-X, a novel tool to support clinician-patient shared decision-making by explaining the CVD risk contributions of different factors and facilitating what-if analysis. Petal-X relies on a novel visualization, Petal Product Plots, and a tailor-made global surrogate model of SCORE2, whose fidelity is comparable to that of the GSCs used in clinical practice. We evaluated Petal-X compared to GSCs in a controlled experiment with 88 healthcare students, all but one with experience with chronic patients. The results show that Petal-X outperforms GSC in critical tasks, such as comparing the contribution to the patient's 10-year CVD risk of each modifiable risk factor, without a significant loss of perceived transparency, trust, or intent to use. Our study provides an innovative approach to the visualization and explanation of risk in clinical practice that, due to its model-agnostic nature, could continue to support next-generation artificial intelligence risk assessment models.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑